Based on a request by the ACR Insurance Subcommittee, off-label use of mycophenolate for scleroderma has been added to a Medicare-approved compendium.
EULAR/ACR Criteria Identify SLE in Hospitalized Pericarditis Patients
NEW YORK (Reuters Health)—New European League Against Rheumatism/American College of Rheumatology (EULAR/ACR) classification criteria can be used to identify patients with systemic lupus erythematosus (SLE) in an unselected group of patients hospitalized for pericardial effusion, new findings show.1 “Overall, in patients with pericardial effusion and positive ANA, the diagnosis of SLE could be ruled out…
Tears of Knee Ligaments & Meniscus Carry Highest Arthritis Risk
(Reuters Health)—Young adults who have had knee injuries are much more likely than uninjured peers to develop knee osteoarthritis (OA) by middle age, especially if they have broken bones or torn connective tissue, a recent study suggests. Cruciate ligament injuries were associated with a 19.6% greater risk of knee osteoarthritis, the study found. Meniscal tears…
Phase 3 Results for Ixekizumab Promising in Patients with Non-Radiographic Axial Spondyloarthritis
In a phase 3 study, ixekizumab proved safe and effective for improving the signs and symptoms of non-radiographic axial spondyloarthritis (axSpA) in combination with conventional background medications, such as NSAIDs…
The Educator’s Toolbox: How Clinicians Can Master the Art of Teaching & Giving Effective Feedback
Insights into how to effectively teach & communicate feedback to students were offered in this Annual Meeting session…
ACR Advocacy: 2019 Year in Review
As a new year begins, Government Affairs Committee chair Blair Solow, MD, takes stock of ACR advocacy wins in 2019 and issues to watch in 2020.
2019 MIPS Reporting with the RISE Registry
The Rheumatology Informatics System for Effectiveness (RISE) 2019 MIPS submission tool will open in mid-January. RISE staff are in the process of completing final data refreshes and reviews to ensure data accuracy. The ACR will notify all practices as soon as the submission tool is open. Practices are requested to complete their submission by March…
EU Approves Remsima SC, a Biosimilar to Infliximab
Subcutaneous CT-P13 (Remsima SC), biosimilar to infliximab, will soon be available in the E.U. to treat adults with rheumatoid arthritis…
Gender Disparity in Invited Commentary Authorship
A case-control study found only 23% of invited commentaries for peer-reviewed medical journals had women as their corresponding authors. The study also revealed women are 21% less likely to write such commentaries as men with similar expertise and author seniority…
New ACR/EULAR IgG4 Classification Criteria Introduced
Immunoglobulin G4-related disease (IgG4-RD) can cause fibroinflammatory lesions in nearly any organ. Correlation among clinical, serologic, radiologic and pathologic data is required for diagnosis. ACR/EULAR classification criteria for IgG4-RD have now been developed and validated in a large cohort of patients…
- « Previous Page
- 1
- …
- 225
- 226
- 227
- 228
- 229
- …
- 816
- Next Page »